Mesa Laboratories (NASDAQ: MLAB - Get Free Report) and ImmunoPrecise Antibodies (OTCMKTS:IPATF - Get

Wells Fargo analyst Evan Stampler maintains Mesa Laboratories (NASDAQ:MLAB) with a Equal-Weight a

Mesa Laboratories, Inc. (MLAB) Q1 2027 Earnings Call Transcript

Mesa Laboratories NASDAQ: MLAB reported first-quarter fiscal 2027 revenue growth of 1%, improved ope

Mesa Laboratories (NASDAQ:MLAB) reported quarterly earnings of $2.68 per share which beat the analys

LAKEWOOD, Colo., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, ou

Lakewood, Colo., July 06, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, ou

Mesa Laboratories fell after reporting its Q4 fiscal 2026 results. Sales and earnings came in below

Mesa Laboratories (NASDAQ:MLAB) reported quarterly earnings of $3.30 per share which beat the analys

LAKEWOOD, Colo., May 27, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “

LAKEWOOD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a

LAKEWOOD, Colo. , April 02, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us,

Mesa Laboratories, Inc. (NASDAQ: MLAB - Get Free Report)'s stock price passed above its two hundred

US stocks rise with Dow up over 300 points, S&P 500 and NASDAQ also gaining. Kohl's Corp sha

US stocks mixed, Dow down 0.1%, NASDAQ up 0.13%, S&P 500 down 0.08%. Materials sector up, utilit

Mesa Laboratories, Inc. (NASDAQ: MLAB) ("Mesa" or "the Company"), a global leader in

Five of the Fund's 10 equity sectors made a positive impact on calendar year performance, led by Ind

Principal Financial Group Inc. lessened its stake in Mesa Laboratories, Inc. (NASDAQ: MLAB) by 66.2%

Diamond Hill Capital Management Inc. grew its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:

Wells Fargo analyst Brandon Couillard maintains Mesa Laboratories (NASDAQ:MLAB) with a Equal-Weig

Mesa Laboratories (NASDAQ:MLAB) reported quarterly earnings of $3.07 per share this is a 12.87 perce

Mesa Laboratories (NASDAQ: MLAB - Get Free Report) is projected to issue its Q3 2026 results before

Mesa Laboratories, Inc. (MLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

LAKEWOOD, Colo., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, ou

LAKEWOOD, Colo., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global l

Wells Fargo analyst Brandon Couillard maintains Mesa Laboratories (NASDAQ:MLAB) with a Equal-Weig

Mesa Laboratories (NASDAQ: MLAB - Get Free Report) and Accuray (NASDAQ: ARAY - Get Free Report) are

LAKEWOOD, Colo., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today annou

Mesa Laboratories (NASDAQ:MLAB) reported quarterly earnings of $2.75 per share which beat the analys

LAKEWOOD, Colo., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue

https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20250905-1479730/1479730_sept202

Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today a

Wells Fargo analyst Brandon Couillard upgrades Mesa Laboratories (NASDAQ:MLAB) from Underweight t

Mesa Laboratories (NASDAQ:MLAB) reported quarterly earnings of $2.32 per share which beat the analys

Wells Fargo analyst Brandon Couillard maintains Mesa Laboratories (NASDAQ:MLAB) with a Underweigh

Mesa Laboratories (NASDAQ:MLAB) reported quarterly earnings of $2.25 per share which beat the analys

U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensio